Abrocitinib combined with low-dose corticosteroids in the management of tattoo-related cutaneous sarcoidosis: a case report
Open Access
- 4 September 2025
- journal article
- case report
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 36 (1) , 2556487
Abstract
Sarcoidosis is a chronic, multisystem granulomatous disorder characterized histologically by non-caseating granulomas. Despite the availability of various therapeutic options, long-term disease control remains a significant clinical challenge. We report the case of a 55-year-old female diagnosed with sarcoidosis. Skin and lymph node biopsies revealed non-caseating granulomatous inflammation, and chest CT indicated pulmonary involvement. Infectious causes of granulomatous disease, including Mycobacterium tuberculosis, non-tuberculous mycobacteria, and fungal infections, were excluded through com-prehensive testing. The patient initially received conventional systemic corticosteroid therapy but developed treatment-related complications. Due to the need for sustained disease control, an alternative regimen combining low-dose corticosteroids with the selective JAK1 inhibitor abrocitinib was initiated. The patient showed significant clinical improvement following the combination therapy, with no observed treatment-related adverse events. This case suggests that low-dose corticosteroids combined with a JAK1 inhibitor such as abrocitinib may represent a treatment option for patients with sarcoidosis.Keywords
Funding Information
- Scientific Research Fund of the Zhejiang Provincial Traditional Chinese Medicine Science and Technology Program (2025ZL463)
This publication has 7 references indexed in Scilit:
- Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving storyAnnals of the Rheumatic Diseases, 2023
- Cutaneous SarcoidosisClinics in Chest Medicine, 2023
- Eyebrow tattoo-associated sarcoidosis: A case reportFrontiers in Medicine, 2022
- ‘Inked the skin deep through the heart’: cardiac sarcoidosis after eyebrow tattooingEuropean Heart Journal - Case Reports, 2022
- Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future ProspectsFrontiers in Immunology, 2020
- Tattoos and self‐reported adverse events in sarcoidosis patientsJournal of the European Academy of Dermatology and Venereology, 2019
- The Diagnosis, Differential Diagnosis, and Treatment of SarcoidosisDeutsches Ärzteblatt international, 2016